Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
Standard
Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency. / Santamaria, Manuel; Neth, Olaf; Douglass, Jo A; Krivan, Gergely; Kobbe, Robin; Bernatowska, Ewa; Grigoriadou, Sofia; Bethune, Claire; Chandra, Anita; Horneff, Gerd; Borte, Michael; Sonnenschein, Anja; Kralickova, Pavlina; Ramón, Silvia Sánchez; Langguth, Daman D; Gonzalez-Granado, Luis Ignacio; Alsina, Laia; Querolt, Montse; Griffin, Rhonda; Hames, Carrie; Mondou, Elsa; Price, Jeffrey; Sanz, Ana; Lin, Jiang.
In: J CLIN IMMUNOL, Vol. 42, No. 3, 04.2022, p. 512-513.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
AU - Santamaria, Manuel
AU - Neth, Olaf
AU - Douglass, Jo A
AU - Krivan, Gergely
AU - Kobbe, Robin
AU - Bernatowska, Ewa
AU - Grigoriadou, Sofia
AU - Bethune, Claire
AU - Chandra, Anita
AU - Horneff, Gerd
AU - Borte, Michael
AU - Sonnenschein, Anja
AU - Kralickova, Pavlina
AU - Ramón, Silvia Sánchez
AU - Langguth, Daman D
AU - Gonzalez-Granado, Luis Ignacio
AU - Alsina, Laia
AU - Querolt, Montse
AU - Griffin, Rhonda
AU - Hames, Carrie
AU - Mondou, Elsa
AU - Price, Jeffrey
AU - Sanz, Ana
AU - Lin, Jiang
PY - 2022/4
Y1 - 2022/4
U2 - 10.1007/s10875-022-01219-3
DO - 10.1007/s10875-022-01219-3
M3 - Other (editorial matter etc.)
C2 - 35174440
VL - 42
SP - 512
EP - 513
JO - J CLIN IMMUNOL
JF - J CLIN IMMUNOL
SN - 0271-9142
IS - 3
ER -